Coverage
-
January 09, 2013
A Missouri federal judge on Tuesday refused to sanction Forest Laboratories Inc. over CEO Howard Solomon's deposition testimony in a multidistrict litigation over the suicide risks of the antidepressant drugs Lexapro and Celexa, ruling that Soloman did not behave inappropriately when answering questions.
9 other articles on this case.
View all »